Efficient biological process characterization by definitive-screening designs: the formaldehyde treatment of a therapeutic protein as a case study |
| |
Authors: | Axel Erler Nuria de Mas Philip Ramsey Grant Henderson |
| |
Affiliation: | 1. Microbial Custom Manufacturing–Process Development, Lonza AG, 3930, Visp, Switzerland 2. Microbial Process Research & Development, Lonza Biologics, Inc., Hopkinton, MA, 01748, USA 4. Biologics Manufacturing & Process Development, Bristol-Myers Squibb Company, Devens, MA, 01434, USA 3. Department of Mathematics & Statistics, University of New Hampshire, Durham, NH, 03824, USA
|
| |
Abstract: | As part of the process-characterization campaign of a candidate vaccine product, a recently developed class of three-level designs—definitive-screening designs—was employed to select a quadratic model that describes the effect of six input process parameters, including protein concentration, formaldehyde-to-protein ratio, lysine concentration, reaction duration, pH, and reaction temperature, on a formylation protein-crosslinking reaction. This design requires only 17 experimental runs. The resulting model was then used to simulate 10,000 runs that account for the variability in the inputs expected on manufacturing scale. The extent of protein polymerization was predicted to be within specifications for all simulated runs, demonstrating the robustness of the unit operation for subsequent process validation and future commercial manufacturing. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|